CBD classed as pharmaceutical product: Taiwan regulatory report

In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes including the extraction, and the addition of CBD to cosmetic products, is prohibited.


Restricted content. Do you want to read more?